In February, when the world barely knew the name COVID-19, Marina Oshana had what she thought was the flu or some other bug.
“I’m an avid Jazzerciser. I love to dance. I was working out five or six days a week,” the UC Davis professor emerita of philosophy said on the Dec. 3 edition of UC Davis LIVE. “I noticed during the cardio portion of the class, I would get fatigued. It was very strange. It seemed to come on suddenly.”
A new cloth-based face mask has been developed by researchers that can kill up to 99.99 per cent of bacteria and viruses within 60 minutes of daylight exposure.
Reserachers have developed a reusable cotton face mask that can kill 99.9999 per cent of bacteria and viruses within an hour of exposure to sunlight, according to the study published in the journal ACS Applied Materials and Interfaces, news agency PTI reported. However, live bacteria and viruses on the surface of the mask could still be contagious.
UC Davis Health has rolled out a groundbreaking, highly accurate test that can check for both COVID-19 and flu viruses at the same time, returning “gold-standard” results in 20 minutes.
UC Davis Health is among the first in the nation to roll out a groundbreaking, highly accurate test that can check for both COVID-19 and flu viruses at the same time. It returns results in 20 minutes and the method of testing is considered the gold standard for coronavirus.
The region’s top experts in patient-focused pulmonary health will lead those multidisciplinary teams. A majority of long-haul COVID patients will experience a variety of respiratory symptoms but some may have more subtle symptoms that may require additional input from experts in cardiovascular, immunologic and neurologic medicine.
A drug to treat patients who contracted the novel coronavirus was approved by the FDA on Thursday. The drug, the antiviral remdesivir, was part of clinical trials in Sacramento and used by doctors in the capital city.
The Office of Research and the School of Medicine had planned to introduce their Oct. 30 speaking guest as a professor and the founder and director of the Innovative Genomics Institute at UC Berkeley, and a CRISPR pioneer.
Since being booked for the Distinguished Speaker Series in Research and Innovation, however, Jennifer Doudna has added a new title: Nobel laureate.
